Versor Investments LP Embecta Corp. Transaction History

Versor Investments LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$10.13 - $14.6 $104,632 - $150,803	10,329 Added 49.9%	31,029 $387,000
Q1 2024 May 13, 2024	BUY	$12.35 - $19.33 $255,645 - $400,130	20,700 New	20,700 $274,000
Q2 2023 Aug 07, 2023	SELL	$21.6 - $30.69 $208,828 - $296,710	-9,668 Reduced 46.36%	11,185 $241,000
Q1 2023 May 05, 2023	BUY	$23.07 - $32.77 $481,078 - $683,352	20,853 New	20,853 $586,000
Q3 2022 Oct 25, 2022	BUY	$24.0 - $33.42 $636,120 - $885,797	26,505 New	26,505 $763,000

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.